Literature DB >> 10924129

Determination of transport kinetics of chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast.

E F Grollman1, N J Philp, P McPhie, R D Ward, B Sauer.   

Abstract

Monocarboxylate transporters (MCTs) comprise a group of highly homologous proteins that reside in the plasma membrane of almost all cells and which mediate the 1:1 electroneutral transport of a proton and a lactate ion. The isoform MCT3 is restricted to the basal membrane of the retinal pigment epithelium where it regulates lactate levels in the neural retina. Kinetic analysis of this transporter poses formidable difficulties due to the presence of multiple lactate transporters and their complex interaction with MCTs in adjacent cells. To circumvent these problems, we expressed both the MCT3 gene and a green fluorescent protein-tagged MCT3 construct in Saccharomyces cerevisiae. Since L-lactate metabolism in yeast depends on the CYB2 gene, we disrupted CYB2 to study the MCT3 transporter activity free from the complications of metabolism. Under these conditions L-lactate uptake varied inversely with pH, greater uptake being associated with lower pH. Whereas the V(max) was invariant, the K(m) increased severalfold as the pH rose from 6 to 8. In addition, MCT3 was highly resistant to a number of "classical" inhibitors of lactate transport. Last, studies with diethyl pyrocarbonate and p-chloromercuribenzenesulfonate set limitations on the locus of potential residues involved in the critical site of lactate translocation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924129     DOI: 10.1021/bi000464+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

Review 1.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

2.  Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT).

Authors:  Ivano Moschen; Angelika Bröer; Sandra Galić; Florian Lang; Stefan Bröer
Journal:  Neurochem Res       Date:  2012-08-10       Impact factor: 3.996

3.  Analysis of the binding moiety mediating the interaction between monocarboxylate transporters and carbonic anhydrase II.

Authors:  Sina Ibne Noor; Steffen Dietz; Hella Heidtmann; Christopher D Boone; Robert McKenna; Joachim W Deitmer; Holger M Becker
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

4.  Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1.

Authors:  Atsuko Okamura; Akiko Emoto; Noriko Koyabu; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 5.  The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

Authors:  Andrew P Halestrap; David Meredith
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

6.  Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat.

Authors:  Annette E Allen; Elizabeth A Martin; Katherine Greenwood; Claire Grant; Peter Vince; Robert J Lucas; William S Redfern
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

7.  The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein.

Authors:  Matthew J Ovens; Christine Manoharan; Marieangela C Wilson; Clarey M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-10-15       Impact factor: 3.857

8.  Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.

Authors:  Yoshifumi Nakayama; Takayuki Torigoe; Yuzuru Inoue; Noritaka Minagawa; Hiroto Izumi; Kimitoshi Kohno; Koji Yamaguchi
Journal:  Exp Ther Med       Date:  2011-10-07       Impact factor: 2.447

9.  Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle.

Authors:  Marieangela C Wilson; David Meredith; Chotirote Bunnun; Richard B Sessions; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

10.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

Authors:  Matthew J Ovens; Andrew J Davies; Marieangela C Wilson; Clare M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.